Prometheus Biosciences Inc (RXDX) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Prometheus Biosciences Inc   (NASDAQ: RXDX)


Prometheus Biosciences Inc's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Prometheus Biosciences Inc's ROI in the third quarter of 2023?
Prometheus Biosciences Inc recorded a cumulative net loss of $-151 million during 12 months ending in the third quarter of 2023, resulting in a negative return on investment (ROI) of -30.84%.

Within the Healthcare sector 445 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Mar 31 2023 quarter, so far to 3968, from total ROI ranking in the fourth quarter of 2022 at 4194.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2023)
III. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Investment Change TTM 84.78 % 28.12 % -6.46 % 8.27 % 37.55 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 739 718 275 221 236
Return On Investment (TTM) -30.84 % -39.1 % -54.05 % -50.06 % -40.99 %
RXDX's Overall Ranking # 3968 # 4194 # 0 # 0 # 0
Seq. Investment Change TTM 34.67 % 47.44 % 0.1 % -7.03 % -6.62 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -151 -142 -133 -123 -108

RXDX Company Profile >> Back to RXDX Roi Comparisons >> See Annual RXDX Return On Investment



Return On Investment RXDX's Ranking
Within: No.
Industry # 166
Sector # 446
Overall # 3968

Return On Investment Statistics
High Average Low
-30.84 %
-53.68 %
-83.72 %
(Mar 31 2023)   (Sep 30 2017)







Financial Statements
Prometheus Biosciences Inc's III. Quarter Investments $ 739 Millions RXDX's Balance sheet
Prometheus Biosciences Inc's III. Quarter Income $ -41 Millions Quarterly RXDX's Income Statement
RXDX's Income by Division See RXDX's Income by Division


RXDX Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015		 (Dec 31 2014)
2014
Total Investments in Millions 718 251 126 171 78
Y / Y Investment Growth 185.63 % 98.85 % -26.25 % 120.22 % 50.28 %
Net Income in Millions -142 -90 -104 -92 -40
Y / Y Net Income Growth - - - - -
Annual Return On Investment -19.74 % -35.88 % -81.99 % -53.95 % -51.38 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
RXDX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for RXDX's Competitors
Subscribers only: Roi for Prometheus Biosciences Inc's Suppliers
Subscribers only: Return On Investment for RXDX's Customers

Other Ratios
RXDX's Roa RXDX's Inventory Turnover Ratio RXDX's Growth Rates RXDX's Dividend Statistics
RXDX's Profitability Ratios RXDX's Asset Turnover Ratio RXDX's Dividend Growth
RXDX's Roe RXDX's Valuation Ratios RXDX's Financial Strength Ratios RXDX's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2023, within Healthcare Sector ROI

Date modified: 2026-09-26T07:39:22+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.